Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Health Related Quality of Life (HRQL) and Symptom Assessment in Patients Diagnosed With Diffuse Intrinsic Pontine Glioma (DIPG) or Recurrent and Re-irradiated Brain Tumours and Their Caregivers: A Non-Therapeutic Study

NCT04670016 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT04670016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04670016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Health Related Quality of Life (HRQL) and Symptom Assessment in Patients Diagnosed With Diffuse Intrinsic Pontine Glioma (DIPG) or Recurrent and Re-irradiated Brain Tumours and Their Caregivers: A Non-Therapeutic Study
Lead sponsor
University of Calgary
Phase
Observational
Overall status
Completed
Start date
July 2, 2020
Completion date
March 30, 2026
Enrollment
20 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, dipg, brain tumor, pediatric, brain tumor, pediatric, recurrent, dipg, radiation exposure, radiation toxicity